PL372809A1 - Podstawione pochodne 1,3-difenyloprop-2-en-1-onu,sposób otrzymywania i zastosowanie podstawionych pochodnych 1,3-difenyloprop-2-enu-1-onu - Google Patents

Podstawione pochodne 1,3-difenyloprop-2-en-1-onu,sposób otrzymywania i zastosowanie podstawionych pochodnych 1,3-difenyloprop-2-enu-1-onu

Info

Publication number
PL372809A1
PL372809A1 PL03372809A PL37280903A PL372809A1 PL 372809 A1 PL372809 A1 PL 372809A1 PL 03372809 A PL03372809 A PL 03372809A PL 37280903 A PL37280903 A PL 37280903A PL 372809 A1 PL372809 A1 PL 372809A1
Authority
PL
Poland
Prior art keywords
derivatives
diphenylprop
substituted
preparation
relates
Prior art date
Application number
PL03372809A
Other languages
English (en)
Other versions
PL207362B1 (pl
Inventor
Jamila Najib
Karine Caumont-Bertrand
Original Assignee
Genfit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfit filed Critical Genfit
Publication of PL372809A1 publication Critical patent/PL372809A1/pl
Publication of PL207362B1 publication Critical patent/PL207362B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708—Ethers
    • C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Wynalazek dotyczy nowych podstawionych pochodnych 1,3-difenyloprop-2-en-1-onu, farmaceutycznych kompozycji zawierających te pochodne, ich zastosowań terapeutycznych, w szczególności do leczenia niedokrwienia mózgowego. Wynalazek dotyczy również sposobu otrzymywania tych pochodnych.
PL372809A 2002-07-08 2003-07-08 Podstawione pochodne 1,3-difenyloprop-2-en-1-onu, sposób otrzymywania tych związków , kompozycje farmaceutyczne zawierające te związki oraz zastosowanie tych związków PL207362B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0208571A FR2841900B1 (fr) 2002-07-08 2002-07-08 Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations

Publications (2)

Publication Number Publication Date
PL372809A1 true PL372809A1 (pl) 2005-08-08
PL207362B1 PL207362B1 (pl) 2010-12-31

Family

ID=29725283

Family Applications (1)

Application Number Title Priority Date Filing Date
PL372809A PL207362B1 (pl) 2002-07-08 2003-07-08 Podstawione pochodne 1,3-difenyloprop-2-en-1-onu, sposób otrzymywania tych związków , kompozycje farmaceutyczne zawierające te związki oraz zastosowanie tych związków

Country Status (24)

Country Link
US (3) US7943661B2 (pl)
EP (1) EP1525177B1 (pl)
JP (1) JP4575771B2 (pl)
KR (1) KR100974577B1 (pl)
CN (1) CN100548960C (pl)
AT (1) ATE365703T1 (pl)
AU (1) AU2003264698B2 (pl)
BR (1) BRPI0312398B8 (pl)
CA (1) CA2490986C (pl)
CY (1) CY1108085T1 (pl)
DE (1) DE60314633T2 (pl)
DK (1) DK1525177T3 (pl)
EA (1) EA011090B1 (pl)
ES (1) ES2287528T3 (pl)
FR (1) FR2841900B1 (pl)
IL (2) IL165696A0 (pl)
MX (1) MXPA05000427A (pl)
NO (1) NO329700B1 (pl)
NZ (1) NZ538051A (pl)
PL (1) PL207362B1 (pl)
PT (1) PT1525177E (pl)
SI (1) SI1525177T1 (pl)
WO (1) WO2004005233A1 (pl)
ZA (1) ZA200501082B (pl)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2841900B1 (fr) 2002-07-08 2007-03-02 Genfit S A Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations
FR2841784B1 (fr) * 2002-07-08 2007-03-02 Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations
AU2005209446A1 (en) * 2004-01-08 2005-08-11 Genfit 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
FR2902789A1 (fr) 2006-06-21 2007-12-28 Genfit Sa Derives de 1,3-diphenylpropane substitues, preparations et utilisations
US20100285126A1 (en) * 2007-08-02 2010-11-11 Rahul Dabre Pharmaceutical compositions of fenofibrate
US9221751B2 (en) 2009-11-26 2015-12-29 Genfit Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
TR201810393T4 (tr) 2009-11-26 2018-08-27 Genfit Karaciğer rahatıszlıklarının tedavisi için 1,3-difenilprop-2-en-1-on türevlerinin kullanımı.
US10722575B2 (en) 2009-11-26 2020-07-28 Genfit Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
WO2011080276A1 (en) 2009-12-29 2011-07-07 Genfit Pharmaceutical combinations comprising a dpp-4 inhibitor and a 1,3-diphenylprop-2-en-1-one derivative
MX2012013359A (es) 2010-05-17 2013-02-11 Genfit Preparacion mejora de derivados de chalcona.
TWI415600B (zh) * 2011-08-10 2013-11-21 Univ Kaohsiung Medical 用於治療動脈粥狀硬化的組合物及其製備方法
WO2013098374A1 (en) 2011-12-28 2013-07-04 Genfit 1,3-diphenylpropane derivatives, preparations and uses thereof
CN102697757B (zh) * 2012-05-18 2014-06-04 广州军区广州总医院 对羟基苄叉丙酮在制备预防和/或治疗脑病药物中的应用
SG11201505281PA (en) * 2013-01-18 2015-08-28 Genfit Methods of treatment of fibrosis and cancers
WO2017143038A1 (en) * 2016-02-16 2017-08-24 Concert Pharmaceuticals, Inc. Deuterated gft-505
CN114796237B (zh) 2016-03-31 2024-02-23 基恩菲特公司 胆汁淤积性疾病的治疗方法
FR3056909B1 (fr) * 2016-09-30 2019-04-19 Nashpharm Composition comprenant au moins un sel pharmaceutiquement acceptable d'elafibranor soluble en milieux aqueux presentant une absorption intestinale amelioree
FR3056908B1 (fr) 2016-09-30 2019-04-19 Nashpharm Sel de metformine et d'elafibranor presentant une activite duale pour le traitement de l'obesite associee a la steato-hepatite non alcoolique (nash) et a l'hypertriglyceridemie
CA3047098A1 (en) * 2016-12-16 2018-06-21 Jia Zhou Inhibitors of bromodomain-containing protein 4 (brd4)
CN110312705B (zh) * 2017-01-22 2021-07-09 苏州科睿思制药有限公司 Gft-505的晶型及其制备方法和用途
AU2018223146B2 (en) 2017-02-21 2023-12-21 Genfit Combination of a PPAR agonist with a FXR agonist
BR112019017314A2 (pt) 2017-02-24 2020-04-14 Genfit composições farmacêuticas para terapia de combinação
CN110536682B (zh) 2017-04-18 2023-01-06 基恩菲特公司 依拉非诺或其衍生物与抗nash、抗纤维化或抗胆汁淤积药剂的组合
CN108658908B (zh) 2017-07-31 2019-05-10 广州必贝特医药技术有限公司 1，3-二取代烯酮类化合物及其应用
WO2019025017A1 (en) 2017-08-04 2019-02-07 Advitech Advisory And Technologies Sa PROCESS FOR THE PREPARATION OF ELAFIBRANOR AND NEW SYNTHETIC INTERMEDIATES
US20200276178A1 (en) 2017-09-13 2020-09-03 Novartis Ag Combinations comprising fxr agonists
US20200283381A1 (en) 2017-11-16 2020-09-10 Teva Pharmaceuticals International Gmbh Solid state forms of elafibranor
EP3719010B1 (en) 2017-11-30 2023-07-26 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Aromatic compound, pharmaceutical composition thereof and use thereof
EP3514541A1 (de) 2018-01-17 2019-07-24 Siemens Healthcare Diagnostics Products GmbH Verfahren zur quantitativen bestimmung eines therapeutischen tnf-alpha inhibitors
WO2019186410A1 (en) * 2018-03-27 2019-10-03 Lupin Limited Solid forms of elafibranor and processes thereof
WO2020025789A1 (en) 2018-08-03 2020-02-06 Genfit Elafibranor salts
WO2020039297A1 (en) * 2018-08-24 2020-02-27 Mankind Pharma Ltd. Novel compounds and their use in preparation of elafibranor and pharmaceutical acceptable salts thereof
WO2020115628A1 (en) * 2018-12-03 2020-06-11 Mankind Pharma Ltd. Solid forms of elafibranor and process of preparation thereof
CN110156648A (zh) * 2019-05-30 2019-08-23 河北科技大学 一种Elafibranor中间体的制备方法
EP3996698A1 (en) * 2019-07-09 2022-05-18 DSM IP Assets B.V. Reducing the viral activity of elafibranor with riboflavin or dha
WO2021083912A1 (en) 2019-10-28 2021-05-06 Genfit Combination therapy having antioxydant properties
WO2021098885A1 (zh) * 2019-11-21 2021-05-27 杭州百诚医药科技股份有限公司 α-氟代查耳酮类衍生物及其应用
CN111138264B (zh) * 2019-11-29 2023-08-04 温州医科大学 一种丁香醛衍生物及其在制备抗妇科肿瘤药物中的应用
CN113121394B (zh) * 2019-12-30 2022-11-08 中国药科大学 一种苯氧乙酸类衍生物的制备方法
KR20220140760A (ko) 2020-02-10 2022-10-18 장피트 엘라피브라노의 다형체
CN114901641B (zh) * 2020-02-28 2025-06-17 四川科伦博泰生物医药股份有限公司 芳香族化合物及其药物组合物和用途
BR112022023368A2 (pt) 2020-05-18 2022-12-20 Genfit Elafibranor para o tratamento de colangite esclerosante primária
US20230301951A1 (en) 2020-08-26 2023-09-28 Genfit Compositions and methods for the treatment of primary biliary cholangitis
CN113230240B (zh) * 2021-03-22 2022-12-27 广州医科大学 1,3-二苯基丙-2-烯-1-酮衍生物及其应用
CN114853686B (zh) 2021-08-23 2023-06-20 中国药科大学 三氮唑酮类化合物及其医药用途
CN115894379B (zh) 2022-01-20 2025-06-27 哈尔滨三联药业股份有限公司 海因类化合物及其医药用途
IL322676A (en) 2023-03-06 2025-10-01 Genfit Alfibrinor solid dosage forms
US20250064763A1 (en) 2023-08-22 2025-02-27 Ipsen Pharma Methods of treatment of primary biliary cholangitis
WO2025224044A1 (en) 2024-04-22 2025-10-30 Ipsen Pharma Methods of treatment of primary biliary cholangitis
CN118363355B (zh) * 2024-06-19 2024-08-30 武汉名实生物医药科技有限责任公司 一种产品生产实时监控系统

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558612A (en) 1968-05-22 1971-01-26 Dow Chemical Co Substituted phenoxyacetic acids
CH593224A5 (pl) * 1973-10-30 1977-11-30 Taisho Pharmaceutical Co Ltd
US3994955A (en) * 1975-01-20 1976-11-30 G. D. Searle & Co. Substituted phenoxydialkylacetic acids and esters
JPS5278856A (en) 1975-12-26 1977-07-02 Taisho Pharmaceut Co Ltd Preparation of chalcone ethers
US4190671A (en) * 1977-03-17 1980-02-26 Biorex Laboratories Limited Chalcone derivatives
JPS5419947A (en) 1977-07-16 1979-02-15 Taisho Pharmaceut Co Ltd Chalcone derivatives
GB8426424D0 (en) * 1984-10-19 1984-11-28 Biorex Laboratories Ltd Chalcone derivatives
JPS6310720A (ja) 1986-07-01 1988-01-18 Nippon Kayaku Co Ltd ５−リポキシゲナ−ゼ阻害剤および抗アレルギ−剤
JPH023670A (ja) 1988-06-22 1990-01-09 Nippon Oil & Fats Co Ltd アルキルチオカルコン誘導体
CA2003856C (en) 1988-11-25 1996-01-30 Toshio Satoh Therapeutic agent for renal disorders
JPH0442229A (ja) * 1990-06-08 1992-02-12 Fujitsu Ltd レジスト材料およびパターンの形成方法
JPH05255655A (ja) 1992-03-12 1993-10-05 Kanebo Ltd 紫外線吸収剤
JPH06122623A (ja) 1992-10-09 1994-05-06 Minofuaagen Seiyaku Honpo:Goushi 抗腫瘍剤
US5276058A (en) * 1993-06-09 1994-01-04 Nippon Hypox Laboratories Incorporated 3,4-dihydroxychalcone derivatives
DE4327365A1 (de) 1993-08-14 1995-02-16 Boehringer Mannheim Gmbh Verwendung von Phenolen und Phenolderivaten als Arzneimittel mit fibrinogensenkender Wirkung
US5523302A (en) 1993-11-24 1996-06-04 The Du Pont Merck Pharmaceutical Company Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
WO1998027970A2 (en) * 1996-12-24 1998-07-02 National Research Council Of Canada Treatment of diseases or prevention of cellular damage caused by oxygen-containing free radicals
EP0947511A1 (en) 1998-03-30 1999-10-06 F. Hoffmann-La Roche Ag Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity
CN1327384A (zh) 1998-10-20 2001-12-19 韩国科学技术研究院 作为血浆高密度脂蛋白浓度增高剂的生物类黄酮
DE60135904D1 (de) * 2000-01-27 2008-11-06 Takara Bio Inc Arzneien zur behandlung von nervenerkrankungen
EP1330448A2 (en) * 2000-06-20 2003-07-30 Atherogenics, Inc. 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
EP1254759B1 (de) 2001-05-03 2009-03-18 Leister Process Technologies Düse zum Schweissen von Kunststoffbahnen oder -folien
FR2841900B1 (fr) 2002-07-08 2007-03-02 Genfit S A Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations
FR2841784B1 (fr) 2002-07-08 2007-03-02 Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations
FR2857361B1 (fr) 2003-07-08 2005-09-09 Genfit S A PREPARATION DE DERIVES DE 1,3-DIPHENYPROP-2-¼n-1-one
AU2005209446A1 (en) * 2004-01-08 2005-08-11 Genfit 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same

Also Published As

Publication number Publication date
DE60314633D1 (de) 2007-08-09
JP4575771B2 (ja) 2010-11-04
EP1525177B1 (fr) 2007-06-27
EA200500169A1 (ru) 2005-06-30
IL165696A (en) 2012-09-24
AU2003264698A1 (en) 2004-01-23
JP2005532385A (ja) 2005-10-27
IL165696A0 (en) 2006-01-15
US20070032543A1 (en) 2007-02-08
CN100548960C (zh) 2009-10-14
CA2490986C (fr) 2012-09-18
US20110190515A1 (en) 2011-08-04
BRPI0312398B1 (pt) 2016-11-08
NO329700B1 (no) 2010-12-06
CA2490986A1 (fr) 2004-01-15
NZ538051A (en) 2007-11-30
ATE365703T1 (de) 2007-07-15
PL207362B1 (pl) 2010-12-31
US7566737B2 (en) 2009-07-28
DE60314633T2 (de) 2008-02-28
PT1525177E (pt) 2007-09-06
US7943661B2 (en) 2011-05-17
MXPA05000427A (es) 2005-09-30
EP1525177A1 (fr) 2005-04-27
ES2287528T3 (es) 2007-12-16
ZA200501082B (en) 2007-01-31
FR2841900B1 (fr) 2007-03-02
CN1668565A (zh) 2005-09-14
BR0312398A (pt) 2005-04-12
NO20045301L (no) 2005-02-04
DK1525177T3 (da) 2007-10-22
BRPI0312398B8 (pt) 2021-05-25
AU2003264698B2 (en) 2009-09-17
KR20050025327A (ko) 2005-03-14
US20050176808A1 (en) 2005-08-11
KR100974577B1 (ko) 2010-08-06
WO2004005233A1 (fr) 2004-01-15
US8058308B2 (en) 2011-11-15
EA011090B1 (ru) 2008-12-30
CY1108085T1 (el) 2014-02-12
SI1525177T1 (sl) 2007-10-31
FR2841900A1 (fr) 2004-01-09

Similar Documents

Publication Publication Date Title
PL372809A1 (pl) Podstawione pochodne 1,3-difenyloprop-2-en-1-onu,sposób otrzymywania i zastosowanie podstawionych pochodnych 1,3-difenyloprop-2-enu-1-onu
EE200100485A (et) Uudsed ühendid ja kompositsioonid proteaasi inhibiitoritena
WO2004060882A8 (en) Cb 1/cb 2 receptor ligands and their use in the treatment of pain
SE0101387D0 (sv) Novel compounds
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
NO20053644L (no) (2S)-2-[(4S)-4-(2,2-difluorvinyl)-2-oksopyrrolidinyl ]butanamid og farmasoytisk preparat
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
SE9802208D0 (sv) Novel compounds
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
SE0300457D0 (sv) Novel compounds
SE9802209D0 (sv) Novel compounds
NO20034985D0 (no) Nye 5-tio-SS-D-xylopyranosid-derivater, fremgangsmåte for fremstilling derav, farmasöytiske blandinger inneholdende dem og den terapeutiskeanvendelse derav
MXPA05007253A (es) Sales novedosas de derivados anticonvulsivantes.
DE50304524D1 (de) Arzneimittel enthaltend substituierte 2,5-diaminomethyl-1h-pyrrole
PY0229005A (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion
EP1452522A3 (en) Novel compounds and compositions as protease inhibitors
MXPA05003633A (es) 2"-oxo-voruscharina y derivados de la misma.
SE9803277D0 (sv) Novel compounds
UY27563A1 (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilización.
DOP2003000766A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes

Legal Events

Date Code Title Description
RECP Rectifications of patent specification